SCHEMBL7369115

SCHEMBL7369115

CC(=O)C1(c2cccc(Cl)c2)CCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 1/20 0.49
SLC6A3 Q01959 6/20 0.44
SLC6A4 P31645 5/20 0.44
SLC6A2 P23975 4/20 0.44
HDAC4 P56524 1/20 0.44
EP300 Q09472 3/20 0.43
CREBBP Q92793 3/20 0.43
IDO1 P14902 2/20 0.42
KCNH2 Q12809 1/20 0.42
AKR1C1 Q04828 1/20 0.41
CHRNA1 P02708 2/20 0.40
CHRNG P07510 2/20 0.40
CHRNB1 P11230 2/20 0.40
CHRNB2 P17787 2/20 0.40
CHRNB4 P30926 2/20 0.40
CHRNA3 P32297 2/20 0.40
CHRNA4 P43681 2/20 0.40
CHRND Q07001 2/20 0.40
HSD11B1 P28845 1/20 0.40
HCAR3 P49019 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20329719 0.93 CCR2 (0.48) CCR2SLC6A3SLC6A4SLC6A2HDAC4
SCHEMBL5759031 0.86 CCR2 (0.46) CCR2SLC6A3SLC6A4SLC6A2CHRNA1
SCHEMBL9466663 0.85 AKR1C1 (0.59) CCR2SLC6A3SLC6A4SLC6A2HDAC4
SCHEMBL5753450 0.84 OPRM1 (0.45) CCR2SLC6A4KCNH2MEN1KMT2A
SCHEMBL18742689 0.83 LMNA (0.48) CCR2SLC6A3SLC6A4SLC6A2HDAC4
SCHEMBL3110960 0.81 AKR1C1 (0.65) CCR2SLC6A3SLC6A4SLC6A2HDAC4
SCHEMBL29886254 0.81 SLC6A4 (0.49) CCR2SLC6A3SLC6A4SLC6A2HDAC4
SCHEMBL28595250 0.81 SLC6A4 (0.49) CCR2SLC6A3SLC6A4SLC6A2HDAC4
Hydrochloric Acid SCHEMBL28595251 0.80 AKR1C1 (0.62) CCR2SLC6A3SLC6A4SLC6A2HDAC4
SCHEMBL4827909 0.80 AKR1C1 (0.62) CCR2SLC6A3SLC6A4SLC6A2HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0715620-B1 1-ARYLCYCLOALKYL SULPHIDES, SULPHOXIDES AND SULPHONES FOR THE TREATMENT OF DEPRESSION, ANXIETY AND PARKINSON'S DISEASE KNOLL AG (DE) 1998-10-28 EP disclosed
US-5652271-A ANTIDEPRESSANTS, NERVOUS SYSTEM DISORDERS KNOLL AKTIENGESELLSCHAFT (DE) 1997-07-29 US disclosed
EP-0715620-A1 1-ARYLCYCLOALKYL SULPHIDES, SULPHOXIDES AND SULPHONES FOR THE TREATMENT OF DEPRESSION, ANXIETY AND PARKINSON'S DISEASE Knoll AG (DE) 1996-06-12 EP disclosed
WO-1994026704-A1 1-ARYLCYCLOALKYL SULPHIDES, SULPHOXIDES AND SULPHONES FOR THE TREATMENT OF DEPRESSION, ANXIETY AND PARKINSON'S DISEASE THE BOOTS COMPANY PLC (GB) 1994-11-24 WO disclosed